Price
No data yet.
Social Signal Score
Analyst Ratings
36 analystsRevenue
$2.96B+15.72%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Andrew Hider
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 37,500
- Beta
- 0.59
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 2.26
Financials
Revenue
$2.96B+15.7%Net Income
$126.00M-3.1%EBITDA
$474.00M+34.7%Free Cash Flow
$32.00M-91.2%EPS (diluted)
$0.24+0.0%Shares Outstanding (diluted)
518.00M-6.0%Operating Expenses
$864.00MCash & Debt
$2.15BReturn of Capital
$10.00MRevenue by Segment (annual)
$10.86BDividend per Share
$0.01Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $11.24B | $-957.00M | $-1.75 |
| 2024 | $10.64B | $-649.00M | $-1.27 |
| 2023 | $10.36B | $2.66B | $5.25 |
| 2022 | $10.06B | $-2.43B | $-4.83 |
| 2021 | $12.15B | $1.28B | $2.56 |
| 2020 | $11.67B | $1.10B | $2.17 |
| 2019 | $11.36B | $1.00B | $1.97 |
| 2018 | $11.10B | $1.55B | $3.04 |
| 2017 | $10.58B | $602.00M | $1.11 |
| 2016 | $10.16B | $4.96B | $9.09 |
| 2015 | $9.97B | $968.00M | $1.78 |
| 2014 | $10.72B | $2.50B | $4.61 |
| 2013 | $9.41B | $2.01B | $3.70 |
| 2012 | $13.94B | $2.33B | $4.22 |
Valuation
BAXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
114-15.15%Social Signal Score
Mentions (7)
- News (Marketaux)gurufocus.com·13h ago·Positive
BAX Maintained by Citigroup -- Price Target Lowered to $27.00 Baxter International B[+320 characters]
View source ↗ - Newszacks.com·11d ago·Neutral
Here's Why You Should Retain Baxter Stock in Your Portfolio for Now BAX's portfolio reset and growth in connected care and advanced surgery support prospects, but margins, Novum IQ and China pricing remain risks.
View source ↗ - Newsseekingalpha.com·26d ago·Positive
Baxter International Inc. (BAX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript Baxter International Inc. (BAX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
View source ↗ - Newszacks.com·28d ago·Positive
BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure Baxter raises its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs, tariffs and pricing pressure margins.
View source ↗ - Newsdefenseworld.net·45d ago·Negative
Baxter Bros Inc. Invests $12.20 Million in GE Vernova Inc. $GEV Baxter Bros Inc. purchased a new stake in GE Vernova Inc. (NYSE: GEV) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 10,385 shares of the company's stock, valued at approximately $12,201,000. GE Vernova accounts for 1.4% of
View source ↗ - Newsbusinesswire.com·48d ago·Negative
Baxter Announces Pricing for Its Upsized Cash Tender Offers DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the pricing terms for its previously announced cash tender offers (each, an “Offer” and collectively, the “Offers”) of the Company's validly tendered (and not validly withdrawn) notes set forth below (the “Notes”) using a “waterfall” methodology under which the Company will accept the Notes in order of their respective acce…
View source ↗ - News (Marketaux)acquirersmultiple.com·50d ago·Positive
Rich Pzena’s Latest Portfolio: Top 10 Holdings & Biggest Moves Portfolio Snapshot Total Portfolio Valu[+358 characters]
View source ↗
Earnings
Thu, Oct 29(in 3 weeks)
Consensus estimate $0.52 per share
Typical surprise +13.8% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Jul 30$0.56 vs $0.37beat
- Thu, Apr 30$0.36 vs $0.31beat
- Thu, Feb 12$0.44 vs $0.53miss
- Thu, Oct 30$0.69 vs $0.60beat
- Thu, Jul 31$0.59 vs $0.60miss
- Thu, May 1$0.55 vs $0.48beat
Estimates and results for BAX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by BAX officers and directors.
No open-market trades in the recent filings. All 100 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
100 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Ro Khannahouse · CA17 · disclosed Jun 11, 2026 (41d later)Buy$1,001 - $15,000
- Michael T. McCaulhouse · TX10 · disclosed Apr 10, 2026 (18d later)Buy$15,001 - $50,000
- Michael T. McCaulhouse · TX10 · disclosed Feb 12, 2026 (30d later)Buy$50,001 - $100,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (24d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (25d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (25d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Oct 22, 2025 (27d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 3, 2025 (4d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 3, 2025 (28d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 3, 2025 (30d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Sep 15, 2025 (42d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 12, 2025 (17d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 12, 2025 (39d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 12, 2025 (31d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (22d later)Buy$1,001 - $15,000
- Robert P. Bresnahanhouse · PA08 · disclosed Jun 10, 2025 (26d later)Buy$1,001 - $15,000
- Earl Blumenauerhouse · OR03 · disclosed Aug 6, 2024 (28d later)Buy$15,001 - $50,000
- Ro Khannahouse · CA17 · disclosed Feb 5, 2024 (28d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 5, 2024 (28d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 8, 2023 (37d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.